173 related articles for article (PubMed ID: 23553192)
1. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
Lee SW; Park KH; Park S; Kim JH; Hong SY; Lee SK; Choi D; Park YB
Arthritis Rheum; 2013 Jul; 65(7):1902-12. PubMed ID: 23553192
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of nephritis in lupus-prone mice by thalidomide.
Lee SW; Park YB; Yang J; Park KH; Lee SK; Choi KH; Kim BS
Rheumatology (Oxford); 2012 Dec; 51(12):2131-40. PubMed ID: 22923758
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB/WF1 mice.
Lee SW; Kim BS
Clin Exp Rheumatol; 2010; 28(3):393-6. PubMed ID: 20497633
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
5. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
[TBL] [Abstract][Full Text] [Related]
6. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.
Yung S; Zhang Q; Zhang CZ; Chan KW; Lui SL; Chan TM
Arthritis Rheum; 2009 Jul; 60(7):2071-82. PubMed ID: 19565476
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
[TBL] [Abstract][Full Text] [Related]
11. The role of aldosterone blockade in murine lupus nephritis.
Monrad SU; Killen PD; Anderson MR; Bradke A; Kaplan MJ
Arthritis Res Ther; 2008; 10(1):R5. PubMed ID: 18197980
[TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.
Lee H; Kim H; Lee G; Chung HS; Bae H
Br J Nutr; 2013 Jul; 110(1):69-76. PubMed ID: 23181951
[TBL] [Abstract][Full Text] [Related]
13. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
Hu Q; Yang C; Wang Q; Zeng H; Qin W
PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
15. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.
Fismen S; Mortensen ES; Rekvig OP
Immunol Cell Biol; 2011 Jan; 89(1):90-9. PubMed ID: 20548325
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.
Cheng CC; Lee YF; Lan JL; Wu MJ; Hsieh TY; Lin NN; Wang JM; Chiu YT
Lupus; 2013 May; 22(6):554-61. PubMed ID: 23478030
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
McMurray RW; Elbourne KB; Lagoo A; Lal S
J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
[TBL] [Abstract][Full Text] [Related]
19. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
[TBL] [Abstract][Full Text] [Related]
20. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
Okudaira H; Terada E; Okudaira K
Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
